CRIS Current Research Information System

TONELLI, ROBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.960
EU - Europa 2.748
AS - Asia 2.708
SA - Sud America 144
AF - Africa 131
Continente sconosciuto - Info sul continente non disponibili 120
OC - Oceania 1
Totale 8.812
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.900
IT - Italia 1.053
CN - Cina 721
SG - Singapore 681
VN - Vietnam 650
GB - Regno Unito 503
DE - Germania 245
HK - Hong Kong 194
SE - Svezia 182
UA - Ucraina 142
FR - Francia 132
IN - India 127
BR - Brasile 104
RU - Federazione Russa 95
NL - Olanda 92
BD - Bangladesh 81
KR - Corea 70
IE - Irlanda 68
CH - Svizzera 63
JP - Giappone 51
FI - Finlandia 40
ZA - Sudafrica 36
CA - Canada 29
CI - Costa d'Avorio 29
SC - Seychelles 28
EE - Estonia 26
TG - Togo 23
PH - Filippine 21
BE - Belgio 20
JO - Giordania 16
PT - Portogallo 16
AR - Argentina 15
TH - Thailandia 15
GR - Grecia 14
MX - Messico 13
PL - Polonia 13
ES - Italia 11
BG - Bulgaria 10
PK - Pakistan 10
AT - Austria 8
ID - Indonesia 8
TW - Taiwan 8
IR - Iran 7
SA - Arabia Saudita 7
UZ - Uzbekistan 7
EC - Ecuador 6
IQ - Iraq 6
MY - Malesia 6
TR - Turchia 6
CL - Cile 5
JM - Giamaica 5
CO - Colombia 4
KZ - Kazakistan 4
NG - Nigeria 4
PE - Perù 4
TN - Tunisia 4
VE - Venezuela 4
AZ - Azerbaigian 3
LT - Lituania 3
RO - Romania 3
BO - Bolivia 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
HR - Croazia 2
MU - Mauritius 2
NO - Norvegia 2
PS - Palestinian Territory 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BS - Bahamas 1
BZ - Belize 1
CR - Costa Rica 1
CY - Cipro 1
FJ - Figi 1
GL - Groenlandia 1
GP - Guadalupe 1
GT - Guatemala 1
HN - Honduras 1
HU - Ungheria 1
IL - Israele 1
KE - Kenya 1
LB - Libano 1
MA - Marocco 1
MD - Moldavia 1
MK - Macedonia 1
NI - Nicaragua 1
NP - Nepal 1
PA - Panama 1
SV - El Salvador 1
TT - Trinidad e Tobago 1
TZ - Tanzania 1
YE - Yemen 1
Totale 8.692
Salva come PNG Salva come JPEG
Città #
Singapore 445
Southend 428
Ashburn 274
Chandler 241
Parma 237
Fairfield 219
Hong Kong 185
Hefei 173
Bologna 156
Santa Clara 154
Dong Ket 141
Woodbridge 135
Seattle 125
Hanoi 124
San Jose 118
Ho Chi Minh City 114
Wilmington 111
Jacksonville 97
Ann Arbor 92
Cambridge 89
Princeton 88
Houston 86
Beijing 81
Council Bluffs 78
Dublin 66
Seoul 61
Turin 61
Milan 59
Boardman 55
Bern 53
Lauterbourg 48
Los Angeles 48
Dallas 46
Nanjing 44
Reggio Emilia 42
Tokyo 42
Rome 40
Padova 39
Westminster 39
Berlin 30
Abidjan 29
Helsinki 29
New York 29
Lomé 23
Haiphong 22
Buffalo 21
Jinan 21
Bengaluru 20
Frankfurt am Main 19
Mülheim 19
San Diego 19
Brussels 18
Saint Petersburg 18
Changsha 17
Redmond 17
Amman 16
Da Nang 15
Des Moines 15
Shenyang 15
Phoenix 14
Redondo Beach 14
Zhengzhou 13
Hebei 12
Medford 12
Nanchang 12
Senago 12
São Paulo 12
Verona 12
Guangzhou 11
Mahé 11
Mountain View 11
Nuremberg 11
Shanghai 11
Tianjin 11
Toronto 11
Warsaw 11
Falkenstein 10
Munich 10
San Giuliano Milanese 10
Sofia 10
San Lazzaro di Savena 9
Amsterdam 8
Brooklyn 8
Dhaka 8
Florence 8
Hangzhou 8
Hải Dương 8
Jiaxing 8
London 8
Naples 8
Ninh Bình 8
Norwalk 8
Taizhou 8
Atlanta 7
Bangkok 7
Chicago 7
Kuban 7
Rimini 7
Rio de Janeiro 7
Taiyuan 7
Totale 5.541
Salva come PNG Salva come JPEG
Nome #
Antigene MYCN Silencing by BGA002 Inhibits SCLC Progression Blocking mTOR Pathway and Overcomes Multidrug Resistance 637
The MYCN inhibitor BGA002 restores the retinoic acid response leading to differentiation or apoptosis by the mTOR block in MYCN-amplified neuroblastoma 283
Preclinical Pharmacokinetics in Tumors and Normal Tissues of the Antigene PNA Oligonucleotide MYCN-Inhibitor BGA002 269
Anti-gene Peptide Nucleic Acid (PNA) specifically inhibits MYCN expression in human neuroblastoma cells leading to cell growth inhibition and apoptosis. 268
A novel MYCN-specific antigene oligonucleotide deregulates mitochondria and inhibits tumor growth in MYCN-amplified neuroblastoma 250
THE P53 REGULATORY GENE MDM2 IS A DIRECT TRANSCRIPTIONAL TARGET OF MYCN IN NEUROBLASTOMA 240
Antitumor Activity of Sustained N-Myc Reduction in Rhabdomyosarcomas and Transcriptional Block by Antigene Therapy 228
Chitosan nanoparticles for siRNA delivery: influence of nanoparticle composition on gene silencing efficiency 220
p21Waf1/Cip1 is a common target induced by short-chain fatty acid HDAC inhibitors (valproic acid, tributyrin and sodium butyrate) in neuroblastoma cells 219
A Peptide Nucleic Acid Embedding a Pseudopeptide Nuclear Localization Sequence in the Backbone Behaves as a Peptide Mimic 201
In vivo bioluminescence imaging of murine xenograft cancer models with a red-shifted thermostable luciferase. 194
MYCN is a novel oncogenic target in pediatric T-cell Acute Lymphoblastic Leukemia 194
MYCN Impact on High-Risk Neuroblastoma: From Diagnosis and Prognosis to Targeted Treatment 191
Targeted inhibition of NMYC by peptide nucleic acid in N-myc amplified human neuroblastoma cells: cell-cycle inhibition with induction of neuronal cell differentiation and apoptosis 188
METHOD FOR SELECTIVE INHIBITION OF HUMAN N-MYC GENE IN N-MYC EXPRESSING TUMORS THROUGH ANTISENSE AND ANTIGEN PEPTIDO-NUCLEIC ACIDS (PNA) 177
The MYCN oncogene as a specific and selective drug target for peripheral and central nervous system tumors. 176
Expression of BEX1 in acute myeloid leukemia with MLL rearrangements 176
G1 Cell-Cycle Arrest and Apoptosis by Histone Deacetylase Inhibition in MLL-AF9 Acute Myeloid Leukemia Cells Is MLL-AF9 Independent 176
Feasibility and safety of adoptive immunotherapy with ex vivogenerated autologous, cytotoxic T lymphocytes in patients with solid tumor 174
Analisi in vitro ed in vivo dell'attività anti-tumorale dopo inibizione specifica di MYCN mediante PNA-NLS anti-gene nel rabdomiosarcoma umano 174
Transient suppression of MLH1 allows effective single-nucleotide substitution by single-stranded DNA oligonucleotides 173
Inibizione specifica di MYCN e MYC mediante PNA-NLS anti-gene in cellule di medulloblastoma umano: caratterizzazione dell'attività anti-tumorale 169
Precision Anti-Cancer Medicines by Oligonucleotide Therapeutics in Clinical Research Targeting Undruggable Proteins and Non-Coding RNAs 167
Sulforaphane induces apoptosis in rhabdomyosarcoma and restores TRAIL-sensitivity in the aggressive alveolar subtype leading to tumor elimination in mice. 165
Identification of two MLL-MLLT3 (alias MLL-AF9) chimeric transcripts in the MOLM-13 cell line. 163
FDG small animal PET permits early detection of malignant cells in a xenograft murine model. 163
Generation and characterization of bioluminescent xenograft mouse models of MLL-related acute leukemias and in vivo evaluation of luciferase-targeting siRNA nanoparticles 163
MYCN Drives a Tumor Immunosuppressive Environment Which Impacts Survival in Neuroblastoma 162
DOWN- REGULATION OF MLL-AF9,MLL,HOXA9,HOXA10, AND MEIS1 EXPRESSION IS NOT OBLIGATORY FOR MONOCYTE- MACROPHAGE MATURATION IN AML -M5 CELL LINES CARRYNG t(9;11)(p22;q23) 159
Accelerating drug development for neuroblastoma: Summary of the Second Neuroblastoma Drug Development Strategy forum from Innovative Therapies for Children with Cancer and International Society of Paediatric Oncology Europe Neuroblastoma 159
Trisomy 11 with MLL-PTD in a case of infant AML M0 158
Mutational Screening of Transforming Growth Factor Beta2 (TGF-beta 2) Gene in patients with congenital Thrombocytopaenia with Absent Radii (TAR). 157
Circular dichroism study of DNA binding by a potential anticancer peptide nucleic acid targeted against the MYCN oncogene. 155
Down-regulation of HOXA4, HOXA7, HOXA10, HOXA11 and MEIS1 during monocyte-macrophage differentiation in THP-1 cells 148
G1 cell-cycle arrest and apoptosis by histone deacetylase inhibition in MLL-AF9 acute myeloid leukemia cells is p21 dependent and MLL-AF9 independent 148
Facial Nerve Graft in Malignant Tumors: The Role of Facial Rehabilitation 147
Precoce predittività di attecchimento midollare dopo trapianto allogenico di cellule staminali emopoietiche in pazienti pediatrici mediante valutazione del chimerismo emopoietico con metodo multiplex polymerase chain reaction 147
Un modello in vivo per la valutazione della terapia anti-gene PNA-mediata nel neuroblastoma e altre patologie oncologiche con sovraespressione di N-myc. 147
Growth Inhibition and Proapoptotic Activity Induction by IIF and Valproic Acid on RA-resistant Leukemia Cells. 146
ArgBP2, encoding a negative regulator of ABL, is fused to MLL in a case of infant M5 acute myeloid leukemia involving 4q35 and 11q23. 146
Molecular Imaging of Neuroblastoma Progression in TH-MYCN Transgenic Mice 145
Inibizione specifica di MYCN mediante PNA-NLS anti gene in cellule di medullobastoma umano:caratterizzazione dellattività anti-tumorale 144
EX VIVO GENERATION AND EXPANSION OF ANTI-TUMOR CYTOTOXIC T-CELL LINES DERIVED FROM PATIENTS OR THEIR HLA-IDENTICAL SIBLING 137
valutazione preclinica della terapia epigenetica con inibitori delle iston-deacetilasi ( acido valproico) e dna-metiltransferasi ( decitabina ) in leucemie mieloidi acute con riarrangiamenti di MLL 133
Identificazione del primo caso di trisomia 11 e partial tandem duplication del gene MLL in una leucemia acuta mieloide (LAM) MO da paziente Infant 131
Expression of T cell receptor alpha gene (TCRA) in human rhabdomyosarcoma and other musculo-skeletal sarcomas. 124
null 95
Idiopathic Pulmonary Fibrosis: Analysis of Predisposing Variants in Patients with Familial Forms 77
MLL-AF9 oncogene expression affects cell growth but not terminal differentiation and is downregulated during monocyte-macrophage maturation in AML-M5 THP-1 cells 49
Totale 8.812
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.053
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.053
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022749 0 26 79 51 74 50 14 51 35 33 173 163
2022/20231.040 112 122 48 106 74 67 60 54 169 36 95 97
2023/2024404 32 49 25 35 26 77 9 29 10 34 28 50
2024/20251.437 57 149 156 100 205 55 154 37 39 122 90 273
2025/20262.716 185 320 269 234 251 140 210 84 534 182 169 138
2026/2027218 95 123 0 0 0 0 0 0 0 0 0 0
Totale 8.812